“Next Phase” For CED Should Focus On Treatments That Lower Cost, MEDCAC Told
Executive Summary
The next iteration of CMS’ Medicare coverage with evidence development policy should limit application of the reimbursement tool to treatments that can lower overall health care spending, Center for Medical Technology Policy CEO Sean Tunis told the Medicare advisory committee.